Trends and Updates in the Life Sciences: Exploring Implications to the Drug and Device Industries
The life science industry has been continuously evolving over the past years. Significant factors influencing the shift in this sector include rapid technological advancements, new data sources, growing market competition, and increasing consumer demands. These influences encourage companies to implement digital transformations and offer numerous opportunities to remain competitive. The challenge lies in employing an effective data engineering platform that will help companies to seamlessly connect and streamline data and further improve the quality of emerging developments.
In this LIVE Webcast, Goodwin Procter’s life sciences lawyer Laurie A. Burlingame, will provide and present to the audience an in-depth analysis of the recent trends and updates in the life sciences industry. As an expert, Laurie will address important issues such as pharmaceutical forecasts in drug development and industry data management..
Some of the major topics that will be covered in this course are:
- The Life Science Industry: An Overview
- Current and Emerging Trends and Developments
- Implications to the Life Sciences Industry
- Common Risks and Pitfalls
- Practical Tips and Best Compliance Practices
- What Lies Ahead
Goodwin Procter LLP
Who Should Attend:
- Chief Information Officers
- Chief Technology Officers
- Directors of R&D
- Chief Scientific Officers
- Chief Innovation Officers
- Privacy and Data Management Officers
- Business Development Managers
- Top Level Executives
Laurie Burlingame is a partner in the firm’s nationally recognized Life Sciences Practice Group. She represents private and public companies across the spectrum of the life sciences industry, including pharmaceuticals, medical devices, diagnostics and biological materials. Ms. Burlingame also represents leading venture capital firms focused on the life sciences industry in connection with their portfolio company investments.
Ms. Burlingame often serves as outside general counsel to her clients, closely advising management teams and boards of directors on a wide variety of matters throughout the company’s life cycle, including formation and founder issues, venture capital financings, public offerings, mergers and acquisitions, licensing transactions, strategic collaborations, commercial transactions, corporate governance and other general corporate matters.
Print and review course materials
Method of Presentation:
General Knowledge in life sciences
NY Category of CLE Credit:
Areas of Professional Practice
Unlock All The Knowledge and Credit You Need
Leading Provider of Online Continuing Education
It's As Easy as 1, 2, 3
Get Your 1-Year All Access Pass For Only $199
About Goodwin Procter LLP
Goodwin is a leading Am Law 50 and Global 50 law firm, with offices across the United States and in Europe and Asia. Excelling at complex transactional work and high-stakes litigation, the firm combines in-depth legal knowledge with practical business experience to help clients maximize opportunities and manage risk. With more than 1,000 lawyers, Goodwin offers innovative counsel and delivers results through a client-centric and collaborative approach. The firm focuses on matters involving financial institutions, intellectual property, private equity, real estate capital markets, securities litigation/white collar defense, and technology/life sciences. Information may be found at www.goodwinlaw.com. Follow us on Twitter @goodwinlaw.